2013
DOI: 10.1016/j.atherosclerosis.2013.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Impact of serum amyloid A on cellular cholesterol efflux to serum in type 2 diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
29
1
3

Year Published

2015
2015
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 45 publications
(35 citation statements)
references
References 30 publications
2
29
1
3
Order By: Relevance
“…One study found that the CE of HDL in patients with a long duration of DM (>10 years) was lower than that in nondiabetic controls. 32 Similarly, in the present study, baseline CE capacity of patients was impaired compared with that of healthy controls.…”
Section: Discussionsupporting
confidence: 52%
“…One study found that the CE of HDL in patients with a long duration of DM (>10 years) was lower than that in nondiabetic controls. 32 Similarly, in the present study, baseline CE capacity of patients was impaired compared with that of healthy controls.…”
Section: Discussionsupporting
confidence: 52%
“…In adipocytes, macrophages and leucocytes, SAA stimulates the production of cytokines promoting inflammation and a positive feedback on SAA production. An additional hypothesis from our data suggests that SAA also participates in (B) the LPS passage from the gut lumen into the bloodstream, increasing gut permeability, and in (C) LPS maintenance in serum, impairing SR-BI [18,20], one of the receptors responsible for LPS clearance manuscript. RAF and AC contributed to the study conception and design, analysis and interpretation of data, and writing and editing of the manuscript.…”
Section: Discussionmentioning
confidence: 99%
“…When complexed with HDL [44], LPS is cleared by SR-BI in hepatocytes [45] and in other cell types such as macrophages and monocytes, as recently described [46]. The clearance of LPS through SR-BI efficiently determines the magnitude of the inflammatory response, and it has already been shown that SAA is associated with impairment of SR-BI [20]. Thus, the authors suggest that the reduction in SAA serum levels due to the ASO SAA treatment could decrease gut permeability to LPS and also improve SR-BI-mediated LPS clearance, leading to decreased endotoxaemia.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations